Skip to main content
FinSpry Logo
FinSpry
AVTX logo
AVTX
(NASDAQ)
Avalo Therapeutics, Inc.
$17.76-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Avalo Therapeutics (AVTX) Stock Price & Financial Analysis

Avalo Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$18.01 - $18.96
52-Week High$24.27
52-Week Low$6.21
Open$18.54
Volume646.90K
Average Volume (3M)1.71M
Market Cap357.10M
Shares Outstanding20.11M
Price to Sales (P/S)6052.53
Price to Book (P/B)5.23
EV/EBITDA-4.03
Revenue (TTM)59.00K
Net Income (TTM)-84.74M
Free Cash Flow (TTM)-59.69M
EPS (TTM)$-5.34
Profit Margin-143627.12%
Operating Margin-134164.41%
Return on Equity (ROE)-124.03%
Debt to Equity0.03
50-Day MA$16.91
200-Day MA$16.37
52-Week Change166.27%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Avalo Therapeutics

What is the current stock price for AVTX?

As of the latest trading session, AVTX stock trades at $18.15. The 52-week range is $6.21–$24.27, with a day range of $18.01–$18.96.

What is the P/E ratio for AVTX?

The P/E ratio (Price-to-Earnings) for AVTX is shown in the Key Statistics section. This valuation metric helps compare Avalo Therapeutics, Inc. to industry peers.

Does AVTX pay dividends?

Avalo Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AVTX?

Based on 11 analysts, the consensus for AVTX is Buy.

What is the market cap of AVTX?

Avalo Therapeutics's market capitalization is $364.9M, classifying it as a small-cap company. Avalo Therapeutics operates in the Healthcare sector within the Biotechnology industry.